Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JoanneKotz
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JoanneKotz
-
thx
@Ptipirneni! ....@aoifemlbrennan@SamTruex Pearl Huang (Cygnal) Reshma Kewalramani (Vertex) also among the many inspiring women CEOs#creatingnewpatternshttps://twitter.com/Ptipirneni/status/1223089161852407808 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Missed
@SchreiberStuart's talk "Listening to Probes: Individuals and Populations"? Tune in to listen to his engaging tales of chemical discovery here: http://bit.ly/SchreiberTalk#chembio#chemistry#chemtwitter#scitwitterpic.twitter.com/cPl8bEPh1B
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Important read for all working to develop drugs. Particularly critical to me is Eric and Sonia's #2: "We want the shortest path to a safe and effective drug, period". We should all strive to think like patient-scientists.https://twitter.com/cureffi/status/1215262638982225920 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Joanne Kotz proslijedio/la je Tweet
Are you interested in off-target promiscuity and strategies to mitigate? Check out the new perspectives article from AstraZeneca legacy drug discovery programs
@MedChem_DGBrown https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01625 …pic.twitter.com/VopsE36VPQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Despite elevated brain
#amyloid pathology, a unique human case harboring a rare mutation in#APOE is reported by@ytquiroz and colleagues to be resistant to inherited#Alzheimer’s disease | http://go.nature.com/2pHhlVf pic.twitter.com/bCQy6bk1Wv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Can't wait for 11/12
@5pm! Excited to host Ruben L. Gonzalez Jr. and Ann McDermott at Queens College--pls RSVP and share--check out "Building the STEM Pipeline: Diversifying Advanced Introductory Courses" http://tinyurl.com/diversifyingSTEM …@QC_News@GCUrbanEd@iumetccolumbia@CUNYTeacherEdpic.twitter.com/flINXSjjR8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to
@chasz43 and@KronosBio. Great to have Charles back in Boston!https://twitter.com/FierceBiotech/status/1187384781211930624 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Don't forget! Today's
@nytimes features a full-page#FTD awareness ad, our third this fall, designed to bring attention to the impact of young-onset#dementia on families. Please share with your social networks & download a copy of the ad on our website:http://bit.ly/2nU67vIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
A warm welcome to Caroline Stark Beer, our new chief business officer! An experienced business development executive, Caroline comes to us from Alnylam and will play a critical role in leading our business and partnership strategy. More here: http://bit.ly/2njFi42 pic.twitter.com/mJ9elmXXKD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thrilled to have Caroline Stark Beer join as Jnana's CBO, and to work with her and
@jcbarrish to build off the@jnanatx team's amazing progress to scale the company.https://www.jnanatx.com/press-releases/jnana-therapeutics-appoints-caroline-stark-beer-as-chief-business-officer/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
We have 2 open research associate positions
@jnanatx - to join our efforts in immunometabolism and neuroscience -please forward to your networks.https://twitter.com/jnanatx/status/1178749018500997121 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great thread and intriguing results.
#metabolites#immunometabolism#patientdatahttps://twitter.com/DrChoueiri/status/1176829814407254016 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Fabulous opening keynote given by Amy Schulman from
@PolarisVC at#BiotechVCDiversity event hosted by@NewEnglandVC and@biogen. Amy is weaving personal experience and unique industry insights together for a powerful and rousing call to action.#Diversity#biotech#HR#VCpic.twitter.com/XFcJ6v4CTm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matt and Justin at
@hub_bio presenting the@jnanatx RAPID platform. Fantastic#chembio innovation. 1st@jnanatx team poster!pic.twitter.com/pNKJE6jnMt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Exciting paper -
#SLC19A1 transports immunoreactive cyclic dinucleotides#immunometabolism#metabolitetransportershttps://twitter.com/jcornlab/status/1172035304095723520 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
We’re pleased to share that data from the core & extension phases of the DRIVE PK study of mitapivat in patients with pyruvate kinase deficiency were published today in
@NEJMhttp://investor.agios.com/news-releases/news-release-details/agios-announces-publication-data-mitapivat-core-and-extension …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Fantastic start to the CCDS symposium in Rotterdam - happy to be representing
@jnanatx at this important meeting@jcbarrish@JoanneKotzpic.twitter.com/my2YUv9c32
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Catching up on genetic support for FDA approved therapies in 2019. Interesting connection between solriamfetol (approved for excessive sleepiness) and SLC6A3 (associated with sleep duration). https://www.targetvalidation.org/target/ENSG00000142319/associations?fcts=datatype:genetic_association …pic.twitter.com/O8gVeI3GGu
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joanne Kotz proslijedio/la je Tweet
Dear
@SecAzar, The@USCIS reversal of a humanitarian policy is a life-threatening matter. Awaiting your response.pic.twitter.com/XgjqnjTwZg
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.